A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of ...

Researchers believe they have developed a test to identify people who have dormant cancer cells and a drug regimen to kill ...

Alzheimer’s has long been one of medicine’s most frustrating puzzles. Despite decades of research and billions in funding, we still don’t have a cure, and the handful of approved treatments offer only ...

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC ...

More than half of practices within the National Cancer Institute Community Oncology Research Program (NCORP) faced drug shortages in recent years that disrupted patient care and created operational ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect. The compound was developed by Lawrence Livermore National ...

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the United ...